MIRM vs UPST · rev $336.1M vs P/E 74, rev $672.9M
Mirum Pharmaceuticals Inc (MIRM) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Mirum Pharmaceuticals Inc (MIRM) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported MIRM revenue for 2026-06-30 was $336.1M. Net income was -$857.4M. MIRM currently screens at market cap $6.22B.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
MIRM currently screens at market cap $6.22B. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the MIRM and UPST stock pages for the full models.
Not investment advice.